ISIN | LU0615763801 |
---|---|
Valor Number | 12806735 |
Bloomberg Global ID | UBSCC48 LX |
Fund Name | UBS (Lux) Bond SICAV - Convert Global (EUR) (CHF hedged) I-A3-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Other Funds |
EFC Category | Convertibles |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund uses the benchmark FTSE Global Convertible Index – Global Vanilla Hedged EUR Index as reference for performance evaluation, sustainability profile comparison and risk management purposes. The benchmark is not designed to promote ESG characteristics. |
Peculiarities |
Current Price * | 191.81 CHF | 08.10.2025 |
---|---|---|
Previous Price * | 191.02 CHF | 07.10.2025 |
52 Week High * | 191.81 CHF | 08.10.2025 |
52 Week Low * | 158.80 CHF | 07.04.2025 |
NAV * | 191.81 CHF | 08.10.2025 |
Issue Price * | 191.81 CHF | 08.10.2025 |
Redemption Price * | 191.81 CHF | 08.10.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 4,256,182,735 | |
Unit/Share Assets *** | 111,215,848 | |
Trading Information SIX |
YTD Performance | +14.03% |
31.12.2024 - 08.10.2025
31.12.2024 08.10.2025 |
---|---|---|
1 month | +3.26% |
08.09.2025 - 08.10.2025
08.09.2025 08.10.2025 |
3 months | +8.83% |
08.07.2025 - 08.10.2025
08.07.2025 08.10.2025 |
6 months | +20.75% |
08.04.2025 - 08.10.2025
08.04.2025 08.10.2025 |
1 year | +13.67% |
08.10.2024 - 08.10.2025
08.10.2024 08.10.2025 |
2 years | +22.37% |
09.10.2023 - 08.10.2025
09.10.2023 08.10.2025 |
3 years | +28.88% |
10.10.2022 - 08.10.2025
10.10.2022 08.10.2025 |
5 years | +19.92% |
08.10.2020 - 08.10.2025
08.10.2020 08.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 14.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 08.10.2025 |
Goldman Sachs International 0% | 1.52% | |
---|---|---|
Rivian Automotive Inc 3.625% | 1.46% | |
Ping An Insurance (Group) Company of China Ltd. 0.875% | 1.45% | |
Snowflake Inc 0% | 1.13% | |
Affirm Holdings Inc 0.75% | 1.09% | |
Guardant Health Inc 1.25% | 1.09% | |
SBI Holdings Inc 0% | 1.06% | |
Rheinmetall AG 2.25% | 1.06% | |
Gold Pole Capital Co Ltd. 1% | 1.05% | |
Bridgebio Pharma Inc 1.75% | 1.04% | |
Last data update | 31.08.2025 |
TER | 0.61% |
---|---|
TER date | 31.05.2025 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.46% |
Ongoing Charges *** | 0.60% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |